June 27-29 2017

Boston, MA


Register before Friday, April 7th to save up to $300!

Translating the Human Microbiome from Marvel to Safe & Effective Medicines

Why Join the ‘Microbiome Movement’?

Using insight gained from the most successful microbiome organizations across the globe, the only end to end drug development meeting is back to help accelerate emerging and well established companies discover, develop and deliver a new generation of microbiome-based therapeutics.

What’s New for 2017?

A dedicated forum in tackling the challenges of developing a microbiome-based therapeutic, Microbiome Drug Development Summit will use industry case studies to develop your knowledge around four core areas of therapeutic advancement :

  • Scientific Activities- Translating microbiome data into a succesful health-care product
  • Clinical Activities- Obtaining decisive human data in a safe and timely manner
  • Regulatory Activities- Outlining clear regulatory paths that guarantee success
  • Financial Activities- Maximising shareholder value and sustaining growth

We have also introduced NEW 15 minute sessions for more focused discussions around the principles of developing therapeutics.

For more information, click here

"This will be the event for leading drug developers to learn from the latest case studies" - Rodolphe Clerval, CBO, Enterome